Home Tags GEN Edge

Tag: GEN Edge

Biotechnology

Attovia Building Immune-Mediated Disease Pipeline with $90M Series C

-
Biotechnology

StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride

-
Biotechnology

AstraZeneza Commits Up to $11B+ to Chinese Collaborations, Beijing R&D Hub

-
Biotechnology

From Tools to Trials: Editing Therapy Companies Pivot to Development

-
Biotechnology

StockWatch: Trump’s FDA Nominee Eyes Rare Disease-Specific Review Pathways

-
Biotechnology

Without Fundamental Science, How Will the Next Generation of Novel Therapies...

-
Biotechnology

StockWatch: HHS Review of Bird Flu Contract Sinks Moderna Shares

-
Biotechnology

Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options

-
Biotechnology

StockWatch: Bluebird Bio Plunges on Buyout, as Gene Therapy’s Woes Grow

-
Biotechnology

StockWatch: NIH Indirect Cost Cuts Shake Tools Stocks

-
1...789...37Page 8 of 37

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© Copyright@Diwou.Com